• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童肝性卟啉病

Hepatic porphyrias in children.

作者信息

Elder G H

机构信息

Department of Medical Biochemistry, University of Wales College of Medicine, Heath Park, Cardiff, UK.

出版信息

J Inherit Metab Dis. 1997 Jun;20(2):237-46. doi: 10.1023/a:1005313024076.

DOI:10.1023/a:1005313024076
PMID:9211196
Abstract

Clinically overt hepatic porphyria is uncommon in children. The autosomal dominant acute hepatic porphyrias, acute intermittent porphyria (AIP), variegate porphyria (VP) and hereditary coproporphyria (HCP), are rarely present before puberty. Identification of asymptomatic children who have inherited these disorders is an important aspect of the management of the disease in their families and requires either enzymatic or DNA methods. Homozygous variants of AIP, VP and HCP usually present in early childhood and have phenotypes of variable severity. Mutational analysis is currently elucidating the relationship between these disorders and their autosomal dominant counterparts. 5-Aminolaevulinate dehydratase deficiency porphyria is a rare, autosomal recessive acute porphyria that may present at any age. Two cutaneous hepatic porphyrias are seen in children. Porphyria cutanea tarda (PCT), although mainly an adult disease, has been reported in young children with the autosomal dominant (type II) form of the disorder. Hepatoerythropoietic porphyria usually develops before the age of 2 years; patients are homo- or heteroallelic for uroporphyrinogen decarboxylase mutations, at least one of which is known to cause type II PCT.

摘要

临床上明显的肝性卟啉病在儿童中并不常见。常染色体显性遗传性急性肝性卟啉病,即急性间歇性卟啉病(AIP)、迟发性皮肤卟啉病(VP)和遗传性粪卟啉病(HCP),在青春期前很少出现。识别患有这些遗传性疾病的无症状儿童是其家族中该疾病管理的一个重要方面,这需要酶学或DNA检测方法。AIP、VP和HCP的纯合变异通常在儿童早期出现,且具有严重程度各异的表型。突变分析目前正在阐明这些疾病与其常染色体显性对应疾病之间的关系。5-氨基酮戊酸脱水酶缺乏性卟啉病是一种罕见的常染色体隐性遗传性急性卟啉病,可在任何年龄出现。儿童中可见两种皮肤肝性卟啉病。迟发性皮肤卟啉病(PCT)虽然主要是一种成人疾病,但在患有常染色体显性(II型)该疾病的幼儿中也有报道。肝红细胞生成性卟啉病通常在2岁前发病;患者为尿卟啉原脱羧酶突变的纯合子或杂合子,已知其中至少一种突变会导致II型PCT。

相似文献

1
Hepatic porphyrias in children.儿童肝性卟啉病
J Inherit Metab Dis. 1997 Jun;20(2):237-46. doi: 10.1023/a:1005313024076.
2
Murine models of the human porphyrias: Contributions toward understanding disease pathogenesis and the development of new therapies.人类卟啉症的鼠模型:对疾病发病机制的理解和新疗法的发展的贡献。
Mol Genet Metab. 2019 Nov;128(3):332-341. doi: 10.1016/j.ymgme.2019.01.007. Epub 2019 Jan 18.
3
Recent advances on porphyria genetics: Inheritance, penetrance & molecular heterogeneity, including new modifying/causative genes.卟啉症遗传学的最新进展:遗传、外显率和分子异质性,包括新的修饰/致病基因。
Mol Genet Metab. 2019 Nov;128(3):320-331. doi: 10.1016/j.ymgme.2018.11.012. Epub 2018 Nov 30.
4
Human hereditary hepatic porphyrias.人类遗传性肝卟啉症。
Clin Chim Acta. 2002 Nov;325(1-2):17-37. doi: 10.1016/s0009-8981(02)00276-0.
5
Erythropoietic and hepatic porphyrias.红细胞生成性和肝性卟啉病
J Inherit Metab Dis. 2000 Nov;23(7):641-61. doi: 10.1023/a:1005645624262.
6
Heme biosynthesis and the porphyrias.血红素生物合成与卟啉病。
Mol Genet Metab. 2019 Nov;128(3):164-177. doi: 10.1016/j.ymgme.2019.04.008. Epub 2019 Apr 22.
7
Molecular characterization of porphyrias in Italy: a diagnostic flow-chart.意大利卟啉病的分子特征:诊断流程图
Cell Mol Biol (Noisy-le-grand). 2002 Dec;48(8):867-76.
8
Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs).急性肝性卟啉症(AHPs)的发病机制和临床特征。
Mol Genet Metab. 2019 Nov;128(3):213-218. doi: 10.1016/j.ymgme.2019.03.002. Epub 2019 Mar 6.
9
Porphyria cutanea tarda and hepatoerythropoietic porphyria: Identification of 19 novel uroporphyrinogen III decarboxylase mutations.迟发性皮肤卟啉病和肝红细胞生成性卟啉病:19 种新型尿卟啉原 III 脱羧酶突变的鉴定。
Mol Genet Metab. 2019 Nov;128(3):363-366. doi: 10.1016/j.ymgme.2018.11.013. Epub 2018 Nov 28.
10
New form of dual porphyria: coexistent acute intermittent porphyria and porphyria cutanea tarda.双卟啉症的新形式:急性间歇性卟啉症与迟发性皮肤卟啉症并存。
Eur J Clin Invest. 1989 Feb;19(1):20-5. doi: 10.1111/j.1365-2362.1989.tb00190.x.

引用本文的文献

1
Neurodevelopmental retardation and neurological symptoms in homozygous variegate porphyria: two new cases and a literature review.纯合性杂色卟啉症中的神经发育迟缓与神经症状:两例新病例及文献综述
Orphanet J Rare Dis. 2025 Mar 20;20(1):139. doi: 10.1186/s13023-025-03606-6.
2
Understanding Hepatic Porphyrias: Symptoms, Treatments, and Unmet Needs.了解肝性卟啉症:症状、治疗方法和未满足的需求。
Semin Liver Dis. 2024 May;44(2):209-225. doi: 10.1055/s-0044-1787076. Epub 2024 May 17.
3
The Hepatic Porphyrias: Revealing the Complexities of a Rare Disease.

本文引用的文献

1
Gene therapy for erythropoietic porphyrias.
Gene Ther. 1996 Oct;3(10):843-4.
2
Identification of three mutations and associated haplotypes in the protoporphyrinogen oxidase gene in South African families with variegate porphyria.在南非患有混合型卟啉病的家族中,原卟啉原氧化酶基因中三个突变及相关单倍型的鉴定。
Hum Mol Genet. 1996 Jul;5(7):981-4. doi: 10.1093/hmg/5.7.981.
3
A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria.人类原卟啉原氧化酶中的R59W突变导致酶活性降低,在患有混合型卟啉病的南非人中很常见。
《肝性血卟啉病:揭示罕见病的复杂性》
Semin Liver Dis. 2023 Nov;43(4):446-459. doi: 10.1055/s-0043-1776760. Epub 2023 Nov 16.
4
Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives.急性肝卟啉症的诊断和治疗挑战:从罕见的儿科发病到创新治疗和前景。
Orphanet J Rare Dis. 2022 Apr 7;17(1):160. doi: 10.1186/s13023-022-02314-9.
5
Acute Intermittent Porphyria: An Overview of Therapy Developments and Future Perspectives Focusing on Stabilisation of HMBS and Proteostasis Regulators.急性间歇性卟啉病:治疗进展及未来展望概述,重点关注 HMBS 稳定和蛋白稳态调节剂。
Int J Mol Sci. 2021 Jan 12;22(2):675. doi: 10.3390/ijms22020675.
6
Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias.卟啉病诊断——第1部分:卟啉病概述
Curr Protoc Hum Genet. 2015 Jul 1;86:17.20.1-17.20.26. doi: 10.1002/0471142905.hg1720s86.
7
Neuropathic pain in hereditary coproporphyria.遗传性粪卟啉症中的神经性疼痛。
Pak J Med Sci. 2013 Apr;29(2):672-4. doi: 10.12669/pjms.292.3202.
8
Psychosocial aspects of predictive genetic testing for acute intermittent porphyria in norwegian minors.挪威未成年人急性间歇性卟啉病预测性基因检测的社会心理方面
JIMD Rep. 2011;1:1-7. doi: 10.1007/8904_2011_8. Epub 2011 Jun 22.
9
The porphyrias: advances in diagnosis and treatment.卟啉症:诊断和治疗的进展。
Blood. 2012 Nov 29;120(23):4496-504. doi: 10.1182/blood-2012-05-423186. Epub 2012 Jul 12.
10
Hepatoerythropoietic porphyria misdiagnosed as child abuse: cutaneous, arthritic, and hematologic manifestations in siblings with a novel UROD mutation.误诊为虐待儿童的肝红细胞生成性卟啉病:携带新型尿卟啉原脱羧酶突变的同胞的皮肤、关节和血液学表现
Arch Dermatol. 2010 May;146(5):529-33. doi: 10.1001/archdermatol.2010.89.
Nat Genet. 1996 May;13(1):95-7. doi: 10.1038/ng0596-95.
4
Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria.尿卟啉原脱羧酶:人类完整基因序列及三个肝红细胞生成性卟啉病家族的分子研究
Am J Hum Genet. 1996 Apr;58(4):712-21.
5
Homozygous variegate porphyria: an evolving clinical syndrome.纯合性变异型卟啉症:一种不断演变的临床综合征。
Postgrad Med J. 1993 Oct;69(816):781-6. doi: 10.1136/pgmj.69.816.781.
6
Homozygous hereditary coproporphyria caused by an arginine to tryptophane substitution in coproporphyrinogen oxidase and common intragenic polymorphisms.由原卟啉原氧化酶中精氨酸替换为色氨酸及常见基因内多态性引起的纯合子遗传性粪卟啉病。
Hum Mol Genet. 1994 Mar;3(3):477-80. doi: 10.1093/hmg/3.3.477.
7
Neurologic disease in a child with hepatoerythropoietic porphyria.
Pediatr Dermatol. 1994 Sep;11(3):216-21. doi: 10.1111/j.1525-1470.1994.tb00589.x.
8
Hepatoerythropoietic porphyria precipitated by viral hepatitis.病毒性肝炎诱发的肝红细胞生成性卟啉病。
Gut. 1993 Nov;34(11):1632-4. doi: 10.1136/gut.34.11.1632.
9
A molecular defect in coproporphyrinogen oxidase gene causing harderoporphyria, a variant form of hereditary coproporphyria.粪卟啉原氧化酶基因的分子缺陷导致硬卟啉症,这是遗传性粪卟啉症的一种变异形式。
Hum Mol Genet. 1995 Feb;4(2):275-8. doi: 10.1093/hmg/4.2.275.
10
Neonatal bullous eruption as a result of transient porphyrinemia in a premature infant with hemolytic disease of the newborn.
J Am Acad Dermatol. 1995 Aug;33(2 Pt 2):333-6. doi: 10.1016/0190-9622(95)91428-5.